Home » Rigel, AstraZeneca Strike Potential $100 Million Asthma Drug Deal
Rigel, AstraZeneca Strike Potential $100 Million Asthma Drug Deal
AstraZeneca will license an experimental asthma treatment from South San Francisco’s Rigel Pharmaceuticals in a potential $100 million deal, Rigel said.
San Francisco Business Journal
San Francisco Business Journal
Upcoming Events
-
07May
-
14May
-
30May